TVRD
Tvardi Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.91
+3.24%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-35.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 11, 2026 | WYZGA MICHAEL S · director | A-Award | 6,000 | $2.78 |
| Jun 11, 2026 | Shiff Susan Ph.D. · director | A-Award | 6,000 | $2.78 |
| Jun 11, 2026 | Smith Cynthia · director | A-Award | 6,000 | $2.78 |
| Jun 11, 2026 | Shah Sujal · director | A-Award | 6,000 | $2.78 |
| Jun 11, 2026 | HALL WALLACE L JR · director | A-Award | 6,000 | $2.78 |
| Feb 2, 2026 | O'Brien Stephen Paul · officer: Principal Accounting Officer | A-Award | 15,000 | $3.90 |
| Feb 2, 2026 | Conn Avi Daniel · officer: Chief Financial Officer | A-Award | 45,000 | $3.90 |
| Feb 2, 2026 | Kauh John Saewook M.D. · officer: Chief Medical Officer | A-Award | 45,000 | $3.90 |
| Feb 2, 2026 | Alibhai Imran Nizamudin · director, officer: Chief Executive Officer | A-Award | 115,000 | $3.90 |
| Dec 18, 2025 | O'Brien Stephen Paul · officer: Principal Accounting Officer | A-Award | 4,000 | $4.20 |
| Dec 18, 2025 | Alibhai Imran Nizamudin · director, officer: Chief Executive Officer | A-Award | 47,500 | $4.20 |
| Dec 18, 2025 | Conn Avi Daniel · officer: Chief Financial Officer | A-Award | 17,500 | $4.20 |
| Dec 18, 2025 | Kauh John Saewook M.D. · officer: Chief Medical Officer | A-Award | 17,500 | $4.20 |
| May 2, 2025 | HALL WALLACE L JR · director | A-Award | 44,712 | $0.00 |
| May 2, 2025 | Wirk Shaheen · director | A-Award | 176,030 | $0.00 |
| May 2, 2025 | Wirk Shaheen · director | A-Award | 263,164 | $0.00 |
| May 2, 2025 | HALL WALLACE L JR · director | A-Award | 202,044 | $0.00 |
| Apr 21, 2025 | Alibhai Imran Nizamudin · director, officer: Chief Executive Officer | A-Award | 182,320 | $17 |
| Apr 21, 2025 | Larson Jeffrey Leroy · officer: SVP, Research & Development | A-Award | 10,820 | $17 |
| Apr 21, 2025 | O'Brien Stephen Paul · officer: Principal Accounting Officer | A-Award | 7,213 | $17 |
| Apr 21, 2025 | Chen Yixin · officer: VP, Chem, Mfg and Ctrls | A-Award | 7,213 | $17 |
| Apr 21, 2025 | Conn Avi Daniel · officer: Chief Financial Officer | A-Award | 43,547 | $17 |
| Apr 21, 2025 | Kauh John Saewook M.D. · officer: Chief Medical Officer | A-Award | 36,210 | $17 |
| Apr 21, 2025 | Shiff Susan Ph.D. · director | A-Award | 12,000 | $17 |
| Apr 21, 2025 | Wirk Shaheen · director | A-Award | 12,000 | $17 |
| Apr 21, 2025 | WYZGA MICHAEL S · director | A-Award | 12,000 | $17 |
| Apr 21, 2025 | Smith Cynthia · director | A-Award | 12,000 | $17 |
| Apr 21, 2025 | Shah Sujal · director | A-Award | 12,000 | $17 |
| Apr 21, 2025 | HALL WALLACE L JR · director | A-Award | 12,000 | $17 |
| Apr 17, 2025 | Wirk Shaheen · director | A-Award | 4,191 | $0.00 |
Institutional positioning
13F filings over the trailing two quarters
New 16Increased 20Reduced 17Sold out 67
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SLATE PATH CAPITAL LP | Unchanged | 704,118 | May 15, 2026 |
| BLACKROCK, INC. | Reduced | 388,075 | May 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 344,708 | May 15, 2026 |
| AMERICAN FINANCIAL GROUP INC | Unchanged | 223,659 | May 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 182,339 | May 15, 2026 |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | Unchanged | 101,034 | May 15, 2026 |
| STATE STREET CORP | Reduced | 97,231 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 92,100 | May 14, 2026 |
| MORGAN STANLEY | Reduced | 72,894 | May 15, 2026 |
| DUNCAN WILLIAMS ASSET MANAGEMENT, LLC | Reduced | 63,241 | May 5, 2026 |
| UBS GROUP AG | Increased | 50,454 | May 5, 2026 |
| NORTHERN TRUST CORP | Increased | 49,081 | May 14, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 46,872 | May 8, 2026 |
| AQR CAPITAL MANAGEMENT LLC | New Position | 42,192 | May 15, 2026 |
| GREAT LAKES ADVISORS, LLC | New Position | 36,236 | May 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 11, 2026